Search

everythinglearnresearchcommunity

for

Search:↓

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

The skin produces and processes hormones, affecting both local and overall body functions.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Combination of 0.25% finasteride and 3% minoxidil works better than just 3% minoxidil for increasing hair thickness in women.

Hormone Replacement Therapy improves skin health in postmenopausal women by boosting collagen and hydration.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Leydig cell tumors in the ovary can cause high testosterone and male traits in postmenopausal women but are treatable with surgery.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Tinea capitis in adults, especially postmenopausal Black women, needs prompt treatment with oral antifungals to avoid scarring.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Ancient hair can preserve hormones, revealing health and fertility insights.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

Alpha-hydroxy acids, like glycolic acid, safely improve skin issues and work on all skin types.

Estetrol may help prevent hair loss and support hair growth in women.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.